• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4657932)   Today's Articles (3947)   Subscriber (51242)
For: Ahmed T, Kollipara S, Boddu R, Bhattiprolu AK. Biopharmaceutics Risk Assessment-Connecting Critical Bioavailability Attributes with In Vitro, In Vivo Properties and Physiologically Based Biopharmaceutics Modeling to Enable Generic Regulatory Submissions. AAPS J 2023;25:77. [PMID: 37498474 DOI: 10.1208/s12248-023-00837-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2023] [Accepted: 06/16/2023] [Indexed: 07/28/2023]  Open
Number Cited by Other Article(s)
1
Kollipara S, Prabhat PK, Saha P, Gupta S, Naidu VR, Ahmed T. Physiologically Based Biopharmaceutics Modeling Coupled with Biopredictive Dissolution in Development of Bioequivalent Formulation for Mesalamine Enteric Coated Tablet: A Tough Nut to Crack. AAPS PharmSciTech 2024;26:1. [PMID: 39627629 DOI: 10.1208/s12249-024-02990-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2024] [Accepted: 11/01/2024] [Indexed: 12/13/2024]  Open
2
Chougule M, Kollipara S, Mondal S, Ahmed T. A critical review on approaches to generate and validate virtual population for physiologically based pharmacokinetic models: Methodologies, case studies and way forward. Eur J Clin Pharmacol 2024;80:1903-1922. [PMID: 39377787 DOI: 10.1007/s00228-024-03763-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2024] [Accepted: 09/28/2024] [Indexed: 10/09/2024]
3
Krajcar D, Velušček D, Grabnar I. Machine learning driven bioequivalence risk assessment at an early stage of generic drug development. Eur J Pharm Biopharm 2024;205:114553. [PMID: 39490606 DOI: 10.1016/j.ejpb.2024.114553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2024] [Revised: 10/05/2024] [Accepted: 10/20/2024] [Indexed: 11/05/2024]
4
García MA, Paulos C, Ibarra Viñales M, Michelet R, Cabrera-Pérez MÁ, Aceituno A, Bone M, Ibacache M, Cortínez LI, Guzmán M. Modeling and Simulations in Latin-American Generic Markets: Perspectives from Chilean Local Industry, Regulatory Agency, and Academia. Mol Pharm 2024. [PMID: 39454202 DOI: 10.1021/acs.molpharmaceut.4c00764] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2024]
5
Rachapally A, Boddu R, Kollipara S, Ahmed T. Bioequivalence requirements for orally inhaled and nasal drug products and use of novel physiologically based biopharmaceutics modeling approaches for assessing in vivo performance. J Pharm Sci 2024:S0022-3549(24)00440-4. [PMID: 39414080 DOI: 10.1016/j.xphs.2024.10.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2024] [Revised: 10/04/2024] [Accepted: 10/04/2024] [Indexed: 10/18/2024]
6
Bhattiprolu AK, Kollipara S, Boddu R, Ahmed T. Justification of widened dissolution specifications of an extended-release product using physiologically based biopharmaceutics modeling. Xenobiotica 2024;54:781-795. [PMID: 39361244 DOI: 10.1080/00498254.2024.2411980] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2024] [Revised: 09/29/2024] [Accepted: 09/30/2024] [Indexed: 10/15/2024]
7
Boddu R, Kollipara S, Kambam V, Khan SM, Behera S, Murty NN, Baheti N, Choudhury AA, Ahmed T. Novel omeprazole delayed release orally disintegrating tablets for enhanced patient compliance: a case of model informed formulation development. Xenobiotica 2024;54:629-641. [PMID: 39126638 DOI: 10.1080/00498254.2024.2391519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2024] [Revised: 08/07/2024] [Accepted: 08/08/2024] [Indexed: 08/12/2024]
8
Bhattiprolu AK, Kollipara S, Boddu R, Arumugam A, Khan SM, Ahmed T. A Semi-Mechanistic Physiologically Based Biopharmaceutics Model to Describe Complex and Saturable Absorption of Metformin: Justification of Dissolution Specifications for Extended Release Formulation. AAPS PharmSciTech 2024;25:193. [PMID: 39168956 DOI: 10.1208/s12249-024-02904-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2024] [Accepted: 07/26/2024] [Indexed: 08/23/2024]  Open
9
Kollipara S, Martins FS, Jereb R, Krajcar D, Ahmed T. Advancing Virtual Bioequivalence for Orally Administered Drug Products: Methodology, Real-World Applications and Future Outlook. Pharmaceuticals (Basel) 2024;17:876. [PMID: 39065727 PMCID: PMC11279853 DOI: 10.3390/ph17070876] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2024] [Revised: 06/11/2024] [Accepted: 06/28/2024] [Indexed: 07/28/2024]  Open
10
Kollipara S, Chougule M, Boddu R, Bhatia A, Ahmed T. Playing Hide-and-Seek with Tyrosine Kinase Inhibitors: Can We Overcome Administration Challenges? AAPS J 2024;26:66. [PMID: 38862853 DOI: 10.1208/s12248-024-00939-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2024] [Accepted: 05/29/2024] [Indexed: 06/13/2024]  Open
11
Kollipara S, Ahmed T, Chougule M, Guntupalli C, Sivadasu P. Conventional vs Mechanistic IVIVC: A Comparative Study in Establishing Dissolution Safe Space for Extended Release Formulations. AAPS PharmSciTech 2024;25:118. [PMID: 38806735 DOI: 10.1208/s12249-024-02819-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2024] [Accepted: 04/23/2024] [Indexed: 05/30/2024]  Open
12
Boddu R, Kollipara S, Bhattiprolu AK, Parsa K, Chakilam SK, Daka KR, Bhatia A, Ahmed T. Dissolution Profiles Comparison Using Conventional and Bias Corrected and Accelerated f2 Bootstrap Approaches with Different Software's: Impact of Variability, Sample Size and Number of Bootstraps. AAPS PharmSciTech 2023;25:5. [PMID: 38117372 DOI: 10.1208/s12249-023-02710-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2023] [Accepted: 11/27/2023] [Indexed: 12/21/2023]  Open
13
Boddu R, Kollipara S, Bhattiprolu AK, Ahmed T. Novel application of PBBM to justify impact of faster dissolution on safety and pharmacokinetics - a case study and utility in regulatory justifications. Xenobiotica 2023;53:587-602. [PMID: 38062540 DOI: 10.1080/00498254.2023.2289160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2023] [Accepted: 11/26/2023] [Indexed: 12/20/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA